Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Apposite Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 20
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 14
Rounds per year 1.18
Lead investments 8
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 5
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Biopharma
  • Therapeutics
Summary

In 2006 was created Apposite Capital, which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The leading representative office of defined VC is situated in the London.

The higher amount of exits for fund were in 2015. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 27 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. This Apposite Capital works on 0 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year.

The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Anaphore, Bird Rock Bio, Ambrx Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Life Science, Health Care.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Apposite Capital, startups are often financed by 5AM Ventures, Versant Ventures, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, 5AM Ventures, Roche Venture Fund. In the next rounds fund is usually obtained by M Ventures, Versant Ventures, SR One.

Besides them, we counted 4 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Apposite Capital:
Typical Co-investors
Apposite Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Apposite Capital:

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
365.fintech District of Zvolen, Region of Banská Bystrica, Slovakia
Harvard Angel Group Boston, Massachusetts, United States
IFG Healthcare Cincinnati, Ohio, United States
Invivo Capital Partners Barcelona, Catalonia, Spain
Panoramic Ventures Atlanta, Georgia, United States
ProQuest Investments New Jersey, Princeton, United States
SHINMEI Japan, Tokyo
Stableton Financial Switzerland, Zug, Zug
The Longevity Fund California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Bird Rock Bio

Biotechnology
Life Science
Therapeutics
$15M27 Mar 2014 San Diego, California, United States

Ulthera

Beauty
Health Care
Medical
$10M08 Feb 2011 Mesa, Arizona, United States

Convergence Pharmaceuticals

Biotechnology
Health Care
Medical
Neuroscience
$35M05 Oct 2010 England

Biotechnology
Medical Device
Therapeutics
$13M09 Jun 2009 San Diego, California, United States

Bird Rock Bio

Biotechnology
Life Science
Therapeutics
$25M07 Jan 2009 San Diego, California, United States

Serentis

Biopharma
Medical
Pharmaceutical
$7M12 Aug 2008 Cambridge, England, United Kingdom

Serentis

Biopharma
Medical
Pharmaceutical
$20M27 Jun 2007 United Kingdom, England

PharmaKodex

Biotechnology
Hospital
Manufacturing
Medical
Pharmaceutical
$9M21 Nov 2006 Cambridge, Massachusetts, United States

Ambrx

Biopharma
Biotechnology
Health Care
Life Science
Therapeutics
$52M05 Jul 2006 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Apposite Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 20
Average round size 19M
Rounds per year 1.18
Peak activity year 2009
Lead investments 8
Follow on index 0.30
Exits 5
Group Appearance index 0.65

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Bird Rock Bio

Biotechnology
Life Science
Therapeutics
$15M27 Mar 2014 San Diego, California, United States

Ulthera

Beauty
Health Care
Medical
$10M08 Feb 2011 Mesa, Arizona, United States

Convergence Pharmaceuticals

Biotechnology
Health Care
Medical
Neuroscience
$35M05 Oct 2010 England

Biotechnology
Medical Device
Therapeutics
$13M09 Jun 2009 San Diego, California, United States

Bird Rock Bio

Biotechnology
Life Science
Therapeutics
$25M07 Jan 2009 San Diego, California, United States

Serentis

Biopharma
Medical
Pharmaceutical
$7M12 Aug 2008 Cambridge, England, United Kingdom

Serentis

Biopharma
Medical
Pharmaceutical
$20M27 Jun 2007 United Kingdom, England

PharmaKodex

Biotechnology
Hospital
Manufacturing
Medical
Pharmaceutical
$9M21 Nov 2006 Cambridge, Massachusetts, United States

Ambrx

Biopharma
Biotechnology
Health Care
Life Science
Therapeutics
$52M05 Jul 2006 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: